Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma
Sponsor: Revolution Medicines, Inc.
Summary
This Expanded Access Program (EAP) is intended to provide daraxonrasib to eligible adult patients with previously treated metastatic pancreatic adenocarcinoma, who have no comparable or satisfactory alternative therapy and are unable to participate in an ongoing daraxonrasib clinical trial.
Official title: Expanded Access Program to Treat Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma With Daraxonrasib
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-07-08
Healthy Volunteers
Not specified
Conditions
Interventions
daraxonrasib
Oral tablets administered once daily
Locations (73)
Southern Cancer Center
Daphne, Alabama, United States
Southern Cancer Center
Mobile, Alabama, United States
Alaska Oncology and Hematology
Anchorage, Alaska, United States
Honor Health
Scottsdale, Arizona, United States
Care Oncology Center
Chula Vista, California, United States
City of Hope Cancer Center (California)
Duarte, California, United States
USC Norris Comprehensive Cancer Hospital
Los Angeles, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
UCLA Health Westlake Village
Los Angeles, California, United States
University of California
Los Angeles, California, United States
El Camino Health
Mountain View, California, United States
The Kaiser Permanente Medical Group
Roseville, California, United States
Sutter Health
Sacramento, California, United States
Sutter Health
San Francisco, California, United States
NorthBay Health Heidi Y Campini Cancer Center
Vacaville, California, United States
UCSF John Muir Health
Walnut Creek, California, United States
Rocky Mountain Cancer Center
Aurora, Colorado, United States
CommonSpirit Oncology Mercy
Durango, Colorado, United States
Lynn Cancer Institute - Boca Raton Regional Hospital
Boca Raton, Florida, United States
Memorial Cancer Institute
Hollywood, Florida, United States
Mayo Clinic - Florida
Jacksonville, Florida, United States
Sylvester Comprehensive Cancer Center
Miami, Florida, United States
Baptist Hospital of Miami
Miami, Florida, United States
Mount Sinai Medical Center of Florida
Miami Beach, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
The Queen's Medical Center
Honolulu, Hawaii, United States
Illinois Cancer Specialist
Arlington Heights, Illinois, United States
University of Iowa
Waukee, Iowa, United States
Advent Health Shawnee Mission
Merriam, Kansas, United States
University of Kansas Medical Center
Westwood, Kansas, United States
Cancer Center of Kansas
Wichita, Kansas, United States
Baptist Health Lexington
Lexington, Kentucky, United States
LSU LCMC Health Cancer Center
New Orleans, Louisiana, United States
New England Cancer Specialists
Topsham, Maine, United States
Johns Hopkins
Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital)
Detroit, Michigan, United States
Henry Ford Health
Detroit, Michigan, United States
Mayo Clinic Minnesota
Rochester, Minnesota, United States
Park Nicollet Specialty Center
Saint Louis Park, Minnesota, United States
Health Partners Oncology
Saint Paul, Minnesota, United States
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, United States
Mid America Cancer Care
Kansas City, Missouri, United States
Washington University School of Medicine
St Louis, Missouri, United States
Nebraska Cancer Specialists
Omaha, Nebraska, United States
Overlook Medical Center - Medical Diagnostic Associates - Atlantic Medical Group
Morristown, New Jersey, United States
Hirschfeld Oncology
Brooklyn, New York, United States
Memorial Sloan Kettering Cancer Center
Long Island City, New York, United States
NYU Langone Health
New York, New York, United States
The Mount Sinai Hospital
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Duke Cancer Institute
Durham, North Carolina, United States
Carolina BioOncology Institute
Huntersville, North Carolina, United States
Zangmeister Cancer Center
Columbus, Ohio, United States
Premier Health OH
Dayton, Ohio, United States
Premier Health OH
Middletown, Ohio, United States
Mercy Hospital Oklahoma City
Oklahoma City, Oklahoma, United States
Oregon Oncology Specialists
Salem, Oregon, United States
Hematology & Oncology Associates of NEPA
Dunmore, Pennsylvania, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Guthrie Sayre
Sayre, Pennsylvania, United States
Avera Cancer Institute
Sioux Falls, South Dakota, United States
West Cancer Center
Germantown, Tennessee, United States
Sarah Cannon Cancer Institute
Nashville, Tennessee, United States
MD Anderson Cancer Center
Houston, Texas, United States
Seattle Integrative Cancer Center
Renton, Washington, United States
Virginia Mason Medical Center
Seattle, Washington, United States
Swedish Cancer Institute Treatment Center
Seattle, Washington, United States
Marshfield Medical Center
Marshfield, Wisconsin, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
PanOncology Centre
San Juan, Puerto Rico